Venaxis Inc (NASDAQ:APPY)

Data as of Jan 30
 -0.048 / -8.76%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Venaxis, Inc. is a vitro diagnostic company, which is focused on advancing products that addresses unmet human diagnostic needs. The company's research and development activities are currently focused primarily on a human acute appendicitis blood-based test. It is in the business of development and commercialization of innovative products. Venaxis was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Contact Information

Venaxis, Inc.
1585 South Perry Street
Castle Rock Colorado 80104
P:(303) 794-2000
Investor Relations:



Mutual fund holders7.47%
Other institutional14.45%
Individual stakeholders0.23%

Top Executives

Stephen T. LundyPresident, Chief Executive Officer & Director
Jeffrey G. McGonegalChief Financial Officer & Secretary
Lyndal K. HesterbergHead-Research & Development
Donald R. HurdChief Commercial Officer & Senior Vice President
Glen Paul FreibergHead-Regulatory Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.